F10 and atrial fibrillation: In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [ROCKET-AF] randomized trial, patients with AF received either rivaroxaban or warfarin.